JPMorgan Starts Cara Therapeutics (CARA) at Neutral

August 3, 2021 3:58 AM EDT
Get Alerts CARA Hot Sheet
Price: $15.93 +0.50%

Rating Summary:
    10 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 5 | New: 36
Trade Now! 
Join SI Premium – FREE

JPMorgan analyst Jessica Fye initiates coverage on Cara Therapeutics (NASDAQ: CARA) with a Neutral rating and a price target of $16.00.


For an analyst ratings summary and ratings history on Cara Therapeutics click here. For more ratings news on Cara Therapeutics click here.


Shares of Cara Therapeutics closed at $12.15 yesterday.


You May Also Be Interested In





Related Categories

New Coverage